Home | Health | Veterinary Medicine
Greer, a leading developer and provider of allergy immunotherapy products, is pleased to announce it has entered into a strategic supply agreement with Axiom Veterinary Laboratories Ltd., one of the largest providers of clinical pathology diagnostic services throughout the United Kingdom and Europe. Under the terms of the agreement, Greer will provide immunotherapy to Axiom Allergyvet, a division of Axiom Veterinary Laboratories Ltd. “We are excited about our partnership with Axiom, and the opportunity to expand our business in the UK,” says John G. Roby, president and CEO of Greer. “Axiom has an outstanding reputation in the United Kingdom and Europe for quality clinical pathology services. Greer is excited about the opportunity to provide quality immunotherapy treatment sets directly to Axiom Allergyvet, and to partner in bringing world-class service to veterinarians and their patients.” Greer is the only global allergy immunotherapy company which has a full line of immunotherapy products and services to test and treat animals. The company’s veterinary offerings include extracts used in treating allergic animals, and providing immunotherapy prescriptions. Greer’s agreement with Axiom will provide greater customer service for Axiom Allergyvet customers and enable them to receive their orders more quickly. Peter Webb, BVM&S, MRCVS, Managing Director of Axiom says, “This agreement will enable us to offer and improve service to our clients with reduced delivery times. We believe the increased efficiency, combined with Greer’s quality products, will increase our customer satisfaction, which veterinarians will then be able to pass along to consumers in their daily practice.
Article Source: http://www.share.onlypunjab.com
For more information visit www.greerlabs.com
Please Rate this Article
5 out of 54 out of 53 out of 52 out of 51 out of 5
Not yet Rated
